When he was just five, Zach was diagnosed with a form of lymphoma that was very hard to treat. He relapsed, an unfortunate reality for many kids battling cancer. Zach was slipping away. But ALSF-funded research had helped to make possible a clinical trial for a new drug, crizotinib, that targeted and turned off a specific gene that fueled Zach's cancer. Days after taking the drug, Zach was feeling better and his cancer was disappearing. Zach's uplifting story is a reminder that the research we fund can make all the difference in a child's life.